The rise in prostate cancer in Mozambique is unlikely to be due to screening programs based on prostate-specific antigen testing, although it is possible that increased awareness, a greater readiness to perform prostatectomy for urinary symptoms in elderly men and histological examination of operative biopsies might explain the increase observed in its incidence. The gene discussed is KLK3; the disease is prostate carcinoma.